CBT vs TECH · P/E 16, rev $3.71B vs P/E 65, rev $1.22B
Cabot Corporation (CBT) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Cabot Corporation (CBT) is a specialty chemicals company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported CBT revenue for 2025-09-30 was $3.71B. Net income was $376.0M. Revenue was down 7.0% from 2024-09-30 to 2025-09-30. CBT currently screens at market cap $4.29B and trailing P/E 15.7.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
CBT currently screens at market cap $4.29B and trailing P/E 15.7. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the CBT and TECH stock pages for the full models.
Not investment advice.